BEAT BioTherapeutics


BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.

Click here to access the company's website.